Is Altria Group (MO) Fully Valued Or Is More Upside Still On The Table?
Altria Group (MO) is back in focus as investors weigh how management responds to volume pressure and rising costs, while expanding its smoke free brands like NJOY and on! to keep pace with changing consumer habits.
Recent trading has been quietly positive for Altria Group, with a 30 day share price return of 4.99% and a year to date share price gain of 20.36%. The 1 year total shareholder return of 10.52% and very large 5 year total shareholder return north of 100% suggest long term holders have been rewarded, even as shorter term momentum has cooled slightly over the past quarter.
Scan beyond Altria Group and compare its setup with hand picked income ideas using the 6 dividend fortresses for potential high yield candidates built on stronger balance sheets.
After a strong run in Altria Group that now tracks analyst targets closely, the real issue is whether valuation still leaves meaningful upside or if most of the easy gains now sit in the rear view mirror.
Most Popular Narrative: 2% Undervalued
Against Altria Group's last close of $68.98, the most followed narrative fair value of about $70.36 points to only a mild valuation gap, which puts the focus firmly on the assumptions behind that number.
The analysts have a consensus price target of $70.36 for Altria Group based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $82.0, and the most bearish reporting a price target of just $59.0.
Read the complete narrative. Read the complete narrative.
Want to see what is driving that valuation spread on Altria Group? The narrative leans on steady top line assumptions, fatter margins, and a future earnings multiple that implies the market treats this tobacco giant more like a steady compounder rather than a shrinking cash cow. It examines which specific profit and rating assumptions would need to hold for that view to be supported.
Result: Fair Value of $70.36 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Altria Group narrative can break if illicit e-vapor products continue to dominate the category or if synthetic nicotine rivals erode oral segment economics.
Find out about the key risks to this Altria Group narrative.
Another View On Altria Group's Valuation
While the analyst narrative sees Altria Group as only about 2% undervalued, the SWS DCF model lands in a very different place. At a share price of $68.98 against an estimated future cash flow value of $144.76, the stock screens as deeply undervalued. Which lens feels more realistic to you for a mature tobacco business?
Before leaning too heavily on either signal, it helps to understand how cash flow based models react to assumptions about discount rates, margins, and terminal value. Look into how the SWS DCF model arrives at its fair value.
Next Steps
Mixed views on Altria Group so far? If you want to move past headlines and sentiment, consider the full picture of risks and upside by reviewing the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Altria Group?
If Altria Group has sharpened your focus on valuation and income, do not stop here. Broader idea hunting can reveal opportunities this single stock will never show you.
- Target resilient candidates first by scanning a curated set of 11 resilient stocks with low risk scores that aim to keep portfolio swings in check.
- Hunt for potential bargains by reviewing the 32 high quality undervalued stocks that combine appealing pricing with stronger fundamentals.
- Round out your watchlist by checking a focused list of solid balance sheet and fundamentals (23 results) that can help you avoid fragile business models when markets turn.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com